Template:Trichomonas antibiotics - Revision history

Danbot: Convert to AntibioticDose with disease=Trichomonas vaginalis

2026-03-19T23:41:07Z

Convert to AntibioticDose with disease=Trichomonas vaginalis

← Revisión anterior		Revisión del 23:41 19 mar 2026
Línea 1:		Línea 1:
	====Non-Pregnant====		====Non-Pregnant====
	*[[Metronidazole]] 500mg PO BID for 7 days <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon</ref>		*{{AntibioticDose\|disease=Trichomonas vaginalis\|drug=Metronidazole\|dose=500mg PO BID for 7 days\|context=Non-Pregnant}} <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon</ref>
	*[[Tinidazole]] 2g PO once		*{{AntibioticDose\|disease=Trichomonas vaginalis\|drug=Tinidazole\|dose=2g PO once\|context=Non-Pregnant}}

	====Pregnant====		====Pregnant====
	''Only treat if the patient is symptomatic''		''Only treat if the patient is symptomatic''
	*[[Metronidazole]] 500mg PO BID for 7 days <ref>CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm</ref>		*{{AntibioticDose\|disease=Trichomonas vaginalis\|drug=Metronidazole\|dose=500mg PO BID for 7 days\|context=Pregnant}} <ref>CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm</ref>

	====Sexual Partner Treatment====		====Sexual Partner Treatment====
	*Female: Same as above		*Female: Same as above
	*Male: [[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>		*Male: [[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>

Cmwelch2: /* Pregnant */

2024-12-26T03:03:29Z

Pregnant

← Revisión anterior		Revisión del 03:03 26 dic 2024
Línea 4:		Línea 4:

	====Pregnant====		====Pregnant====
	''Only treat if the patient is symptomatic ~~and avoid breast feeding until 24-hrs after last dose~~''		''Only treat if the patient is symptomatic''
	*[[Metronidazole]] 500mg PO BID for 7 days <ref>CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm</ref>		*[[Metronidazole]] 500mg PO BID for 7 days <ref>CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm</ref>

Mbritton: /* Pregnant */

2024-08-30T01:57:00Z

Pregnant

← Revisión anterior		Revisión del 01:57 30 ago 2024
Línea 5:		Línea 5:
	====Pregnant====		====Pregnant====
	''Only treat if the patient is symptomatic and avoid breast feeding until 24-hrs after last dose''		''Only treat if the patient is symptomatic and avoid breast feeding until 24-hrs after last dose''
	*[[Metronidazole]] 2g PO ~~once~~<ref>CDC Trichomoniasis ~~2015~~. https://www.cdc.gov/std/~~tg2015~~/trichomoniasis.htm</ref>		*[[Metronidazole]] 500mg PO BID for 7 days <ref>CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm</ref>

	====Sexual Partner Treatment====		====Sexual Partner Treatment====
	*Female: Same as above		*Female: Same as above
	*Male: [[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>		*Male: [[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>

Rossdonaldson1: /* Sexual Partner Treatment */

2024-06-19T22:43:09Z

Sexual Partner Treatment

← Revisión anterior		Revisión del 22:43 19 jun 2024
Línea 8:		Línea 8:

	====Sexual Partner Treatment====		====Sexual Partner Treatment====
	*~~[[Metronidazole]] 500mg PO BID x 7 days '''OR'''~~		*Female: Same as above
	*[[Tinidazole]] 2g PO once

	*Male: [[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>		*Male: [[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>

Rossdonaldson1: /* Men */

2024-06-19T22:42:29Z

Men

← Revisión anterior		Revisión del 22:42 19 jun 2024
Línea 11:		Línea 11:
	*[[Tinidazole]] 2g PO once		*[[Tinidazole]] 2g PO once

	~~====Men====~~		*Male: [[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>
	*[[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>

Agarrett: /* Men */

2021-12-15T02:28:29Z

Men

← Revisión anterior		Revisión del 02:28 15 dic 2021
Línea 12:		Línea 12:

	====Men====		====Men====
	*[[Metronidazole]] ~~200 mg~~ PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>		*[[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>

Athorne: /* Trichomonas in Men */

2021-07-28T18:42:41Z

Trichomonas in Men

← Revisión anterior		Revisión del 18:42 28 jul 2021
Línea 11:		Línea 11:
	*[[Tinidazole]] 2g PO once		*[[Tinidazole]] 2g PO once

	====~~Women with HIV Infection~~====		====Men====
	*[[Metronidazole]] ~~500~~ mg PO ~~BID x 7 days~~<ref>~~CDC~~. Sexually ~~transmitted diseases treatment guidelines~~. MMWR Recomm Rep ~~2010~~;59(No. RR-12)</ref>		*[[Metronidazole]] 200 mg PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>

Athorne: /* Non-Pregnant */

2021-07-28T18:39:12Z

Non-Pregnant

← Revisión anterior		Revisión del 18:39 28 jul 2021
Línea 1:		Línea 1:
	====Non-Pregnant====		====Non-Pregnant====
	*[[Metronidazole]] ~~2g PO once '''OR'''~~ 500mg PO BID for 7 days <ref>~~Kissinger P~~ et al. ~~Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: An open-label~~, ~~randomised controlled trial~~. ~~Lancet Infect Dis 2018 Oct 5~~; [e-~~pub]~~.</ref>		*[[Metronidazole]] 500mg PO BID for 7 days <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon</ref>
	*[[Tinidazole]] 2g PO once		*[[Tinidazole]] 2g PO once

ClaireLewis at 18:10, 4 October 2019

2019-10-04T18:10:42Z

← Revisión anterior		Revisión del 18:10 4 oct 2019
Línea 12:		Línea 12:

	====Women with HIV Infection====		====Women with HIV Infection====
	*Metronidazole 500 mg PO BID x 7 days<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(No. RR-12)</ref>		*[[Metronidazole]] 500 mg PO BID x 7 days<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(No. RR-12)</ref>

Mholtz at 03:09, 26 November 2018

2018-11-26T03:09:20Z

← Revisión anterior		Revisión del 03:09 26 nov 2018
Línea 1:		Línea 1:
	====Non-Pregnant====		====Non-Pregnant====
	*[[Metronidazole]] 2g PO once or 500mg PO BID for 7 days <ref>Kissinger P et al. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: An open-label, randomised controlled trial. Lancet Infect Dis 2018 Oct 5; [e-pub].</ref>		*[[Metronidazole]] 2g PO once '''OR''' 500mg PO BID for 7 days <ref>Kissinger P et al. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: An open-label, randomised controlled trial. Lancet Infect Dis 2018 Oct 5; [e-pub].</ref>
	*[[Tinidazole]] 2g PO once		*[[Tinidazole]] 2g PO once

Línea 8:		Línea 8:

	====Sexual Partner Treatment====		====Sexual Partner Treatment====
	*[[Metronidazole]] 500mg PO BID x 7 days or [[Tinidazole]] 2g PO once		*[[Metronidazole]] 500mg PO BID x 7 days '''OR'''
			*[[Tinidazole]] 2g PO once

	====Women with HIV Infection====		====Women with HIV Infection====
	*Metronidazole 500 mg PO BID x 7 days<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(No. RR-12)</ref>		*Metronidazole 500 mg PO BID x 7 days<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(No. RR-12)</ref>